109 related articles for article (PubMed ID: 1800016)
1. Therapeutic trial of hematological disorders with intermittent administration of high-dose 1-alpha-hydroxyvitamin D3.
Imai Y; Tsutsumi M; Tsunenari T; Nishikawa M; Matsui T; Natazuka T; Fujita T
Contrib Nephrol; 1991; 91():95-101. PubMed ID: 1800016
[TBL] [Abstract][Full Text] [Related]
2. Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG).
Hellström E; Robèrt KH; Samuelsson J; Lindemalm C; Grimfors G; Kimby E; Oberg G; Winqvist I; Billström R; Carneskog J
Eur J Haematol; 1990 Nov; 45(5):255-61. PubMed ID: 2261951
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 (1 alpha(OH)D3)].
Taoka T; Hamamoto T; Okuda Y; Hata Y; Kubota Y; Tanaka T; Irino S; Miyazaki T; Ohbayashi S
Rinsho Ketsueki; 1987 Jun; 28(6):830-8. PubMed ID: 3478504
[No Abstract] [Full Text] [Related]
4. Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3.
Vardi P; Benderly A; Etzioni A; Levy J; Hochberg Z
Eur J Pediatr; 1985 Sep; 144(3):280-2. PubMed ID: 4054169
[TBL] [Abstract][Full Text] [Related]
5. Hematologic benefits of 1-hydroxyvitamin D3 in an elderly patient with chronic myelodysplastic syndrome.
Motomura S; Fujisawa S; Tsunooka S; Fujimaki K; Mohri H; Okubo T
Am J Hematol; 1996 Oct; 53(2):143-4. PubMed ID: 8892744
[No Abstract] [Full Text] [Related]
6. The effect of 1-hydroxyvitamin D3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes.
Motomura S; Kanamori H; Maruta A; Kodama F; Ohkubo T
Am J Hematol; 1991 Sep; 38(1):67-8. PubMed ID: 1897516
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow and serum concentrations of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1 alpha,25-dihydroxyvitamin D in patients with leukemia and normal subjects.
Masuda S; Okano T; Noma K; Hamasaki M; Kobayashi T; Oh H; Yoshida S
J Nutr Sci Vitaminol (Tokyo); 1989 Aug; 35(4):211-23. PubMed ID: 2585143
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-dose 1-hydroxyvitamin D3 in a patient with myelodysplasia after induction therapy for acute myelocytic leukemia.
Fujisawa S; Motomura S; Sakai R; Tomita N; Fujimaki K; Mohri H; Okubo T
Anticancer Drugs; 1997 Jun; 8(5):466-7. PubMed ID: 9215609
[No Abstract] [Full Text] [Related]
9. Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.
Hirashima K; Bessho M; Jinnai I
Contrib Nephrol; 1991; 88():254-65. PubMed ID: 2040187
[No Abstract] [Full Text] [Related]
10. Growth rate in children with vitamin-D-dependent rickets in relation to 1-alpha-hydroxyvitamin D3 dosage.
Pronicka E; Rowińska E; Buczeń K; Lorenc R; Gradzka I
Endokrynol Pol; 1992; 43(2):145-52. PubMed ID: 1345536
[TBL] [Abstract][Full Text] [Related]
11. Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromes.
Akiyama N; Miyazawa K; Kanda Y; Tohyama K; Omine M; Mitani K; Ohyashiki K
Leuk Res; 2010 Sep; 34(9):1151-7. PubMed ID: 20569983
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effectiveness of vitamin D3 in patients with myelodysplastic syndromes, leukemias and myeloproliferative disorders].
Takahashi T; Ichiba S; Okuno Y; Sugiyama H; Sakai Y; Imura H; Iho S; Hoshino T; Suzuki A; Okada T
Rinsho Ketsueki; 1989 Jan; 30(1):1-10. PubMed ID: 2716194
[TBL] [Abstract][Full Text] [Related]
13. Observation on the use of 1 alpha-hydroxyvitamin D3 in the prevention of bovine parturient paresis: the effect of a single injection on plasma 1 alpha-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3, calcium, and hydroxyproline.
Bar A; Perlman R; Sachs M
J Dairy Sci; 1985 Aug; 68(8):1952-8. PubMed ID: 3840185
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan.
Ko BS; Chang MC; Chiou TJ; Chang TK; Chen YC; Lin SF; Chang CS; Lu YC; Yeh SP; Chen TY; Hwang WS
Hematology; 2019 Dec; 24(1):247-254. PubMed ID: 30558522
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).
Yoshida Y; Asano S; Hirashima K; Takaku F
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():349-52. PubMed ID: 1284304
[No Abstract] [Full Text] [Related]
17. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone.
Birkenhäger-Frenkel DH; Pols HA; Zeelenberg J; Eijgelsheim JJ; Schot R; Nigg AL; Weimar W; Mulder PG; Birkenhäger JC
J Bone Miner Res; 1995 Feb; 10(2):197-204. PubMed ID: 7754799
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
[TBL] [Abstract][Full Text] [Related]
19. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
20. 1 alpha-hydroxy-25-fluorovitamin D3: a potent analogue of 1 alpha,25-dihydroxyvitamin D3.
Napoli JL; Fivizzani MA; Schnoes HK; DeLuca HF
Biochemistry; 1978 Jun; 17(12):2387-92. PubMed ID: 678516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
